ENTO
Entero Therapeutics
ENTO
ENTO
14 hedge funds and large institutions have $168K invested in Entero Therapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 9 closing their positions.
Holders
14
Holders Change
-5
Holders Change %
-26.32%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
8
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$122K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$3K |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$5K |
Top Sellers
1 |
1
BlackRock
New York
|
$4K |
2 |
2
Jane Street
New York
|
$15K |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$0 |
4 |
4
Bank of New York Mellon
New York
|
$0 |
5 |
HF
5
HRT Financial
New York
|
$0 |